Tekmira Pharmaceuticals Corp (NASDAQ:TKMR)

14.22
Delayed Data
As of May 05
 -0.39 / -2.67%
Today’s Change
8.86
Today|||52-Week Range
29.93
-6.14%
Year-to-Date
No recent news for Tekmira Pharmaceuticals Corp.

Today’s Trading

Previous close14.61
Today’s open14.50
Day’s range13.92 - 14.58
Volume997,467
Average volume (3 months)727,563
Market cap$680.3M
Dividend yield--
Data as of 05/05/2015

Growth & Valuation

Earnings growth (last year)-95.65%
Earnings growth (this year)--
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-3.31%
P/E ratio--
Price/Sales22.17
Price/Book3.72

Competitors

 Today’s
change
Today’s
% change
TGTXTG Therapeutics Inc-0.91-6.35%
RGLSRegulus Therapeutics...-0.69-5.13%
EPZMEpizyme Inc-0.72-4.26%
ENTAEnanta Pharmaceutica...-0.67-1.89%
Data as of 05/05/2015

Financials

Last reporting dateMay 6, 2015
EPS forecast (this quarter)-$0.37
Annual revenue (last year)$15.0M
Annual profit (last year)-$38.8M
Net profit margin-259.73%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Murray
Chief Operating Officer
Patrick T. Higgins
Corporate headquarters
Burnaby, British Columbia

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers